Physician profile
Anas Alomar
NPI 1457586844
$9,029.48
in general payments reported to CMS, 2019-2025
39 companies · $1,038 in 2025
The $1,038 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $933 · 2020: $720 · 2021: $1,247 · 2022: $586 · 2023: $2,729 · 2024: $1,776 · 2025: $1,038.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,995 · Travel and Lodging: $1,448 · Education: $99.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,995.46 |
| Travel and Lodging | $1,448.36 |
| Education | $99.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $1,310.69 | 2020-2025 | (9520) Igt Devices Undivided, Extended Holter, (Ck7) Extended Holter |
| Medtronic, INC. | $955.00 | 2021-2025 | Venaseal, Cobalt Dr Mri Surescan, Onyx Frontier |
| Novartis Pharmaceuticals Corporation | $841.02 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $605.55 | 2021-2025 | Verquvo, Capvaxive |
| Astrazeneca Pharmaceuticals LP | $511.67 | 2020-2025 | Farxiga |
| Amgen INC. | $436.18 | 2019-2025 | Repatha, Repatha |
| Astellas Pharma US INC | $428.47 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $398.12 | 2019-2025 | Lifevest |
| Edwards Lifesciences Corporation | $345.46 | 2019-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Janssen Pharmaceuticals, INC | $341.54 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $327.70 | 2019-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $260.77 | 2019-2023 | Nc Trek Neo |
| Pfizer INC. | $234.38 | 2019-2025 | |
| Inari Medical, INC. | $197.25 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Esperion Therapeutics, INC. | $191.87 | 2020-2025 | Nexletol |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $177.56 | 2024-2025 | Opsumit, Uptravi |
| Stryker Corporation | $173.97 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $164.12 | 2019-2025 | Watchman Flx, Bodyguardian, Lux-Dx Insertable Cardiac Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $151.45 | 2022-2025 | Jardiance |
| Bardy Diagnostics, INC. | $118.00 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $98.78 | 2019-2021 | |
| Novo Nordisk INC | $89.84 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $65.66 | 2024-2025 | |
| Vital Connect, INC | $60.08 | 2023-2024 | Vitalpatch Rtm |
| Azurity Pharmaceuticals, INC. | $56.42 | 2024-2025 | Edarbyclor |
| Shockwave Medical, INC | $56.26 | 2022 | |
| Chiesi USA, INC. | $53.66 | 2019-2021 | |
| Amarin Pharma, INC. | $51.73 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $50.06 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $46.45 | 2024 | |
| Kiniksa Pharmaceuticals, LTD. | $43.92 | 2021 | |
| Baxter Healthcare | $32.62 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Lilly USA, LLC | $30.42 | 2023 | Zepbound |
| Kowa Pharmaceuticals America, INC. | $29.67 | 2020-2021 | |
| Inspire Medical Systems, INC. | $22.08 | 2025 | Inspire |
| Atricure, INC. | $20.51 | 2023 | |
| Biotronik INC. | $19.05 | 2019 | |
| Osprey Medical INC | $17.00 | 2019 | |
| Abiomed | $14.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anas Alomar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.